ArticlebioRxiv : the preprint server for biology2026
Modulation of the sensitivity to ruxolitinib-mediated JAK2 inhibition by mutationally activated SHP2 exhibits cell context dependency in pre-clinical models of myeloproliferative neoplasms.
Tegan M Rowsell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.